What is the recommended management for a patient with a soft plaque 70% stenosis of the internal cervical carotid artery?

Management of 70% Soft Plaque Internal Carotid Artery Stenosis

Critical First Determination: Symptomatic vs. Asymptomatic Status

The management hinges entirely on whether this patient has experienced recent neurological symptoms (stroke, TIA, or amaurosis fugax within the past 6 months). 1, 2

---

For SYMPTOMATIC Patients (Recent Stroke/TIA within 6 months)

Immediate Medical Therapy

Initiate dual antiplatelet therapy (DAPT) with aspirin 81-325 mg daily plus clopidogrel 75 mg daily immediately for at least 21 days, then transition to single antiplatelet therapy (aspirin or clopidogrel) long-term. 1, 2

• This DAPT regimen is Class I recommendation for symptomatic carotid stenosis patients not immediately revascularized 1
• Do NOT use full-intensity anticoagulation with heparin or low-molecular-weight heparin, as this is not recommended and provides no benefit 1

Revascularization Decision

Carotid endarterectomy (CEA) should be performed within 14 days of symptom onset if the anticipated 30-day risk of procedural stroke or death is less than 6%. 1, 2, 3

• CEA is the Class I recommendation for symptomatic 70-99% stenosis 1
• The 2-week window is critical because stroke risk is highest immediately after the index event, and benefit is maximized with early intervention 1, 3, 4
• Carotid artery stenting (CAS) is an acceptable alternative if the patient has unfavorable neck anatomy for surgery, but CEA is generally preferred, especially in older patients 1, 2

Optimal Medical Therapy (OMT) - Mandatory for ALL Patients

Implement comprehensive cardiovascular risk reduction regardless of revascularization status: 1, 2, 5

• High-intensity statin therapy 5, 6
• Blood pressure control (target <140/90 mmHg) 5, 6
• Smoking cessation 5, 6
• Mediterranean-style diet and exercise 6

Post-Revascularization Management

• Continue aspirin 81-325 mg daily indefinitely after CEA 1
• For CAS: DAPT with aspirin and clopidogrel for at least 1 month, then long-term single antiplatelet therapy 1
• Duplex ultrasound surveillance within the first month post-procedure 1, 2
• Annual follow-up to assess cardiovascular risk factors and treatment adherence 1, 2

---

For ASYMPTOMATIC Patients

Routine revascularization is NOT recommended for asymptomatic 70% stenosis in the modern era of optimal medical therapy, particularly if life expectancy is less than 5 years or in the absence of high-risk plaque features. 1

Medical Management Strategy

Initiate single antiplatelet therapy with aspirin 81-325 mg daily (or clopidogrel 75 mg if aspirin-intolerant) plus comprehensive cardiovascular risk factor modification. 1

• The benefit of aspirin in asymptomatic carotid stenosis remains unproven in randomized trials, but observational data supports its use in high-risk patients (e.g., diabetics) 1
• Consider dual pathway inhibition (aspirin 100 mg plus rivaroxaban 2.5 mg twice daily) in very high-risk patients, though specific data for asymptomatic carotid stenosis are limited 1

When to Consider Revascularization in Asymptomatic Patients

CEA may be reasonable in highly selected asymptomatic patients with >70% stenosis IF: 1

• Life expectancy >5 years 1
• Perioperative stroke/MI/death risk is demonstrably low (<3%) 1
• Patient has high-risk features (though these are still being defined) 5
• Thorough discussion of risks and benefits with patient understanding and preference 1

However, the absolute benefit is only approximately 1% per year, and modern medical therapy has significantly reduced stroke risk to <1% annually. 5, 7

---

Critical Pitfalls to Avoid

• Do NOT delay revascularization beyond 14 days in symptomatic patients - the benefit diminishes significantly with time 1, 3, 4
• Do NOT use DAPT (aspirin + clopidogrel) beyond 21-90 days in symptomatic patients not undergoing revascularization - transition to single antiplatelet therapy 1
• Do NOT perform revascularization if the surgeon's perioperative stroke/death rate exceeds 6% - the benefit is negated 1, 6
• Do NOT assume all 70% stenoses require intervention - asymptomatic patients often do better with medical therapy alone in the current era 1, 5
• Confirm stenosis measurement using NASCET method - other methods (ECST) overestimate severity and are not recommended 1, 2

---

Assessment by Multidisciplinary Team

All patients with symptomatic carotid stenosis should be evaluated by a vascular team including a neurologist to determine optimal management strategy. 1, 2